Guided Therapeutics (GTHP) EBIT Margin Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 103,166.00 |
| Sep 30, 2025 | -60,963.00 |
| Dec 31, 2024 | -5.24 Mn |
| Mar 31, 2024 | -455,556.00 |
| Dec 31, 2023 | -44,658.00 |
| Jun 30, 2023 | 271,705.00 |
| Mar 31, 2023 | 556,818.00 |
| Sep 30, 2022 | -3.67 Mn |
| Jun 30, 2022 | -1.37 Mn |
| Mar 31, 2022 | -641,238.00 |
| Dec 31, 2021 | -95,422.00 |
| Sep 30, 2021 | -184,842.00 |
| Dec 31, 2020 | 1.60 Mn |
| Sep 30, 2020 | 2.28 Mn |
| Dec 31, 2019 | 1.55 Mn |
| Sep 30, 2019 | -782,273.00 |
| Jun 30, 2019 | -1.43 Mn |
| Mar 31, 2019 | 951,433.00 |
| Dec 31, 2018 | -67,887.00 |
| Sep 30, 2018 | -979,302.00 |
| Jun 30, 2018 | -535,327.00 |
| Mar 31, 2018 | -827,725.00 |
| Dec 31, 2017 | -56,786.00 |
| Sep 30, 2017 | -391,760.00 |
| Jun 30, 2017 | -48,718.00 |
| Mar 31, 2017 | -230,890.00 |
| Dec 31, 2016 | 55,087.00 |
| Sep 30, 2016 | -45,529.00 |
| Jun 30, 2015 | -1.59 Mn |